The present invention relates to a recombinant baculovirus comprising: (a) a nucleotide sequence encoding a foreign virus envelope protein； (b) a first promoter operatively linked to the envelope-encoding nucleotide sequence； (c) a nucleotide sequence encoding an antigen protein； and (d) a second promoter operatively linked to the antigen-encoding nucleotide sequence； and a vaccine composition using the same. The recombinant baculovirus of the present invention has an excellent efficacy on both humoral and cellular immune responses against a specific antigen ( e.g ., HPV L1), enabling to function as a more efficient DNA vaccine.
